# Acurx Pharmaceuticals, Inc.: Form SC 13D, filed Jul 6, 2021

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: SC 13D
- Filed: 2021-07-06
- Accepted by EDGAR: Jul 6, 2021, 16:20 ET
- Period: not reported
- Accession: 0001104659-21-089429
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465921089429/tm2121302d6_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465921089429/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465921089429/tm2121302d6_sc13d.htm

Filed Jul 6, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-089429. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
